Signaling by AMP-activated Protein Kinase

Molecular System Bioenergetics: Energy for Life

Volumn , Issue , 2007, Pages 303-338

  Neumann, Dietbert ^a   Wallimann, Theo ^a   Rider, Mark H ^b,c   Tokarska Schlattner, Malgorzata ^d   Hardie, D Grahame ^e   Schlattner, Uwe ^a,d  

^a ETH ZURICH   (Switzerland)

^b DE DUVE INSTITUTE   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Energy transfer networks; Mammalian AMPK; Metabolic feedback regulation; Modeling cellular energetics; Molecular system bioenergetics; Sensing cellular energy stress situations; Signaling by AMP activated protein kinase; Signaling of cellular energy stress situations

Indexed keywords

EID: 58149398449     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527621095.ch9     Document Type: Chapter

References (174)

1. Hardie, D. G., Hawley, S. A., Scott, J. W. (2006) AMP-activated protein kinase-development of the energy sensor concept. J. Physiol. 574 7-15.
2. Alessi, D., Sakamoto, K., Bayascas, J. (2006) LKB1-Dependent Signaling Pathways. Annu. Rev. Biochem. 75 137-163.
3. Sarbassov, D. D., Ali, S. M., Sabatini, D. M. (2005) Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17 596-603.
4. Inoki, K., Guan, K. L. (2006) Complexity of the TOR signaling network. Trends Cell Biol. 16 206-212.
5. Wullschleger, S., Loewith, R., Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124 471-484.
6. Saks, V., Dzeja, P., Schlattner, U., Vendelin, M., Terzic, A., Wallimann, T. (2006) Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J. Physiol. 571 253-273.
7. Neumann, D., Schlattner, U., Wallimann, T. (2003) A molecular approach to the concerted action of kinases involved in energy homoeostasis. Biochem. Soc. Trans. 31 169-174.
8. Hardie, D. G., Sakamoto, K. (2006) AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology 21 48-60.
9. Atkinson, D. E. (1968) The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7 4030-4034.
10. Hardie, D. G., Hawley, S. A. (2001) AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23 1112-1119.
11. Hardie, D. G. (2000) Metabolic control: a new solution to an old problem. Curr. Biol. 10, R757-759.
12. Kahn, B. B., Alquier, T., Carling, D., Hardie, D. G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 15-25.
13. Fryer, L. G., Carling, D. (2005) AMPactivated protein kinase and the metabolic syndrome. Biochem. Soc. Trans. 33 362-366.
14. Witters, L. A., Kemp, B. E., Means, A. R. (2006) Chutes and Ladders: the search for protein kinases that act on AMPK. Trends Biochem. Sci. 31 13-16.
15. Hallows, K. R. (2005) Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism. Curr. Opin. Nephrol. Hypertens. 14 464-471.
16. Hardie, D. G. (2007) AMP-Activated Protein Kinase as a Drug Target. Annu. Rev. Pharmacol. Toxicol. 47 185-210.
17. Luo, Z., Saha, A. K., Xiang, X., Ruderman, N. B. (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26 69-76.
18. Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., Eppenberger, H. M. (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281 21-40.
19. Wallimann, T., Hemmer, W. (1994) Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133-134, 193-220.
20. Noma, T. (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J. Med. Invest. 52 127-136.
21. Kinukawa, M., Nomura, M., Vacquier, V. D. (2007) A sea urchin sperm flagellar adenylate kinase with triplicated catalytic domains. J. Biol. Chem. 282 2947-2955.
22. Wallimann, T. (1996) 31P-NMRmeasured creatine kinase reaction flux in muscle: a caveat! J. Muscle Res. Cell Motil. 17 177-181.
23. Martonosi, A., Gouvea, M. A., Gergely, J. (1960) Studies on actin.III. G-F transformation of actin and muscular contraction (experiments in vivo). J. Biol. Chem. 235 1707-1710.
24. Hancock, C. R., Brault, J. J., Wiseman, R. W., Terjung, R. L., Meyer, R. A. (2005) 31P-NMR observation of free ADP during fatiguing, repetitive contractions of murine skeletal muscle lacking AK1. Am. J. Physiol. 288, C1298-1304.
25. Hancock, C. R., Janssen, E., Terjung, R. L. (2006) Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinasedeficient mice. J. Appl. Physiol. 100 406-413.
26. Ingwall, J. S. (2002) Is creatine kinase a target for AMP-activated protein kinase in the heart? J. Mol. Cell. Cardiol. 34 1111-1120.
27. Hellsten, Y., Richter, E. A., Kiens, B., Bangsbo, J. (1999) AMP deamination and purine exchange in human skeletal muscle during and after intense exercise. J. Physiol. 520 909-920.
28. Wadley, G. D., Lee-Young, R. S., Canny, B. J., Wasuntarawat, C., Chen, Z. P., Hargreaves, M., Kemp, B. E., McConell, G. K. (2006) Effect of exercise intensity and hypoxia on skeletal muscle AMPK signaling and substrate metabolism in humans. Am. J. Physiol. 290, E694-702.
29. McGilvery, R. W., Murray, T. W. (1974) Calculated equilibria of phosphocreatine and adenosine phosphates during utilization of high energy phosphate by muscle. J. Biol. Chem. 249 5845-5850.
30. Wallimann, T., Schnyder, T., Schlegel, J., Wyss, M., Wegmann, G., Rossi, A. M., Hemmer, W., Eppenberger, H. M., Quest, A. F. (1989) Subcellular compartmentation of creatine kinase isoenzymes, regulation of CK and octameric structure of mitochondrial CK: important aspects of the phosphoryl-creatine circuit. Prog. Clin. Biol. Res. 315 159-176.
31. Dzeja, P. P., Zeleznikar, R. J., Goldberg, N. D. (1996) Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J. Biol. Chem. 271 12847-12851.
32. Schlattner, U., Wallimann, T. (2004) Metabolite channeling: creatine kinase microcompartments, in Encyclopedia of Biological Chemistry (Lennarz, W. J., Lane, M. D., Eds.) pp 646-651, Academic Press, New York, USA.
33. Schlattner, U., Tokarska-Schlattner, M., Wallimann, T. (2006) Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 1762 164-180.
34. Matthews, P. M., Bland, J. L., Gadian, D. G., Radda, G. K. (1982) A 31P-NMR saturation transfer study of the regulation of creatine kinase in the rat heart. Biochim. Biophys. Acta 721 312-320.
35. Wyss, M., Smeitink, J., Wevers, R. A., Wallimann, T. (1992) Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim. Biophys. Acta 1102 119-166.
36. Winnard, P., Cashon, R. E., Sidell, B. D., Vayda, M. E. (2003) Isolation, characterization and nucleotide sequence of the muscle isoforms of creatine kinase from the Antarctic teleost Chaenocephalus aceratus. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 134 651-667.
37. Sheng, X. R., Li, X., Pan, X. M. (1999) An iso-random Bi Bi mechanism for adenylate kinase. J. Biol. Chem. 274 22238-22242.
38. Li, X., Han, Y., Pan, X. M. (2001) Cysteine-25 of adenylate kinase reacts with dithiothreitol to form an adduct upon aging of the enzyme. FEBS Lett. 507 169-173.
39. Dzeja, P. P., Terzic, A., Wieringa, B. (2004) Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Mol. Cell. Biochem. 256-257, 13-27.
40. Suter, M., Riek, U., Tuerk, R., Schlattner, U., Wallimann, T., Neumann, D. (2006) Dissecting the role of 50-AMP for allosteric stimulation, activation and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281 32207-32216.
41. Rush, J. W., Tullson, P. C., Terjung, R. L. (1998) Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion. Am. J. Physiol. 274, C465-471.
42. Janero, D. R., Yarwood, C. (1995) Oxidative modulation and inactivation of rabbit cardiac adenylate deaminase. Biochem. J. 306 421-427.
43. Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., Shulman, G. I. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 99 15983-15987.
44. Newby, A. C. (1988) The pigeon heart 50-nucleotidase responsible for ischaemia-induced adenosine formation. Biochem. J. 253 123-130.
45. Yamazaki, Y., Truong, V. L., Lowenstein, J. M. (1991) 50-Nucleotidase I from rabbit heart. Biochemistry 30 1503-1509.
46. Leff, T. (2003) AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem. Soc. Trans. 31 224-227.
47. Saks, V., Favier, R., Guzun, R., Schlattner, U., Wallimann, T. (2006) Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands. J. Physiol. 577 769-777.
48. Dyck, J. R., Lopaschuk, G. D. (2006) AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol. 574 95-112.
49. Viollet, B., Foretz, M., Guigas, B., Horman, S., Dentin, R., Bertrand, L., Hue, L., Andreelli, F. (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol. 574 41-53.
50. Ju, J. S., Smith, J. L., Oppelt, P. J., Fisher, J. S. (2005) Creatine feeding increases GLUT4 expression in rat skeletal muscle. Am. J. Physiol. 288, E347-352.
51. Jorgensen, S. B., Treebak, J. T., Viollet, B., Schjerling, P., Vaulont, S., Wojtaszewski, J. F., Richter, E. A. (2007) Role of {alpha}2-AMPK in basal, trainingand AICAR-induced GLUT4, hexokinase II and mitochondrial protein expression in mouse muscle. Am. J. Physiol. 292, E331-339.
52. Ceddia, R. B., Sweeney, G. (2004) Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells. J. Physiol. 555 409-421.
53. Bergeron, R., Ren, J. M., Cadman, K. S., Moore, I. K., Perret, P., Pypaert, M., Young, L. H., Semenkovich, C. F., Shulman, G. I. (2001) Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. 281, E1340-1346.
54. Ponticos, M., Lu, Q. L., Morgan, J. E., Hardie, D. G., Partridge, T. A., Carling, D. (1998) Dual regulation of the AMPactivated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 17 1688-1699.
55. Taylor, E. B., Ellingson, W. J., Lamb, J. D., Chesser, D. G., Compton, C. L., Winder, W. W. (2006) Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate. Am. J. Physiol. 290, E661-669.
56. Eijnde, B. O., Derave, W., Wojtaszewski, J. F., Richter, E. A., Hespel, P. (2005) AMP kinase expression and activity in human skeletal muscle: effects of immobilization, retraining, and creatine supplementation. J. Appl. Physiol. 98 1228-1233.
57. Hardie, D. G., Scott, J. W., Pan, D. A., Hudson, E. R. (2003) Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546 113-120.
58. Davies, S. P., Helps, N. R., Cohen, P. T., Hardie, D. G. (1995) 50-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 377 421-425.
59. Berridge, M. J. (2006) Calcium microdomains: Organization and function. Cell Calcium 40 405-412.
60. Berridge, M. J., Bootman, M. D., Roderick, H. L. (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4 517-529.
61. Hardie, D. G., Carling, D. (1997) The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246 259-273.
62. Zaccolo, M., Di Benedetto, G., Lissandron, V., Mancuso, L., Terrin, A., Zamparo, I. (2006) Restricted diffusion of a freely diffusible second messenger: mechanisms underlying compartmentalized cAMP signalling. Biochem. Soc. Trans. 34 495-497.
63. Carling, D., Clarke, P. R., Zammit, V. A., Hardie, D. G. (1989) Purification and characterization of the AMP-activated protein kinas. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities.. Eur. J. Biochem. 186 129-136.
64. Hardie, D. G., Carling, D., Carlson, M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67 821-855.
65. Lizcano, J. M., Goransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Makela, T. P., Hardie, D. G., Alessi, D. R. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23 833-843.
66. Hardie, D. G. (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144 5179-5183.
67. Elbing, K., Rubenstein, E. M., McCartney, R. R., Schmidt, M. C. (2006) Subunits of the Snf1 kinase heterotrimer show interdependence for association and activity. J. Biol. Chem. 281 26170-26180.
68. Carling, D. (2004) The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 29 18-24.
69. Rudolph, M. J., Amodeo, G. A., Bai, Y., Tong, L. (2005) Crystal structure of the protein kinase domain of yeast AMPactivated protein kinase Snf1. Biochem. Biophys. Res. Commun. 337 1224-1228.
70. Crute, B. E., Seefeld, K., Gamble, J., Kemp, B. E., Witters, L. A. (1998) Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273 35347-35354.
71. Pang, T., Xiong, B., Li, J. Y., Qiu, B. Y., Jin, G. Z., Shen, J. K., Li, J. (2007) Conserved alpha helix acts as autoinhibitory sequence in AMPactivated protein kinase alpha subunits. J. Biol. Chem. 282 495-506.
72. Hudson, E. R., Pan, D. A., James, J., Lucocq, J. M., Hawley, S. A., Green, K. A., Baba, O., Terashima, T., Hardie, D. G. (2003) A Novel Domain in AMPActivated Protein Kinase Causes Glycogen Storage Bodies Similar to Those Seen in Hereditary Cardiac Arrhythmias. Curr. Biol. 13 861-866.
73. Iseli, T. J., Walter, M., van Denderen, B. J., Katsis, F., Witters, L. A., Kemp, B. E., Michell, B. J., Stapleton, D. (2005) AMP-activated Protein Kinase beta Subunit Tethers alpha and gamma Subunits via Its C-terminal Sequence (186-270). J. Biol. Chem. 280 13395-13400.
74. Polekhina, G., Gupta, A., Michell, B. J., van Denderen, B., Murthy, S., Feil, S. C., Jennings, I. G., Campbell, D. J., Witters, L. A., Parker, M. W., Kemp, B. E., Stapleton, D. (2003) AMPK beta Subunit Targets Metabolic Stress Sensing to Glycogen. Curr. Biol. 13 867-871.
75. Polekhina, G., Gupta, A., van Denderen, B. J., Feil, S. C., Kemp, B. E., Stapleton, D., Parker, M. W. (2005) Structural basis for glycogen recognition by AMPactivated protein kinase. Structure 13 1453-1462.
76. Kemp, B. E. (2004) Bateman domains and adenosine derivatives form a binding contract. J. Clin. Invest. 113 182-184.
77. Milan, D., Jeon, J. T., Looft, C., Amarger, V., Robic, A., Thelander, M., Rogel-Gaillard, C., Paul, S., Iannuccelli, N., Rask, L., Ronne, H., Lundstrom, K., Reinsch, N., Gellin, J., Kalm, E., Roy, P. L., Chardon, P., Andersson, L. (2000) A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288 1248-1251.
78. Gollob, M. H., Seger, J. J., Gollob, T. N., Tapscott, T., Gonzales, O., Bachinski, L., Roberts, R. (2001) Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104 3030-3033.
79. Scott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A., Norman, D. G., Hardie, D. G. (2004) CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 113 274-284.
80. Blair, E., Redwood, C., Ashrafian, H., Oliveira, M., Broxholme, J., Kerr, B., Salmon, A., Ostman-Smith, I., Watkins, H. (2001) Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10 1215-1220.
81. Townley, R., Shapiro, L. (2007) Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase. Science 315 1726-1729.
82. Manning, G., Whyte, D., Martinez, R., Hunter, T., Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298 1912-1934.
83. Carling, D. (2005) AMP-activated protein kinase: balancing the scales. Biochimie 87 87-91.
84. Burwinkel, B., Scott, J. W., Buhrer, C., van Landeghem, F. K., Cox, G. F., Wilson, C. J., Grahame Hardie, D., Kilimann, M. W. (2005) Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am. J. Hum. Genet. 76 1034-1049.
85. Arad, M., Benson, D. W., Perez-Atayde, A. R., McKenna, W. J., Sparks, E. A., Kanter, R. J., McGarry, K., Seidman, J. G., Seidman, C. E. (2002) Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Invest. 109 357-362.
86. Hamilton, S. R., Stapleton, D., O'Donnell, J. B., Jr., Kung, J. T., Dalal, S. R., Kemp, B. E., Witters, L. A. (2001) An activating mutation in the gamma1 subunit of the AMP-activated protein kinase. FEBS Lett. 500 163-168.
87. Scott, J. W., Ross, F. A., Liu, J. K. D., Hardie, D. G. (2007) Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the gamma subunit. EMBO J. 26 806-815.
88. Hawley, S. A., Selbert, M. A., Goldstein, E. G., Edelman, A. M., Carling, D., Hardie, D. G. (1995) 50-AMP activates the AMP-activated protein kinase cascade, and Ca2{thorn}/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 270 27186-27191.
89. Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., Alessi, D. R., Hardie, D. G. (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28.
90. Sanders, M. J., Grondin, P. O., Hegarty, B. D., Snowden, M. A., Carling, D. (2006) Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403 139-148.
91. Rafaeloff-Phail, R., Ding, L., Conner, L., Yeh, W. K., McClure, D., Guo, H., Emerson, K., Brooks, H. (2004) Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. J. Biol. Chem. 279 52934-52939.
92. Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., Hardie, D. G. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271 27879-27887.
93. Stein, S. C., Woods, A., Jones, N. A., Davison, M. D., Carling, D. (2000) The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345 437-443.
94. Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., Cantley, L. C. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 101 3329-3335.
95. Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., Carling, D. (2003) LKB1 is the upstream kinase in the AMPactivated protein kinase cascade. Curr. Biol. 13 2004-2008.
96. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2 9-19.
97. Woods, A., Dickerson, K., Heath, R., Hong, S. P., Momcilovic, M., Johnstone, S. R., Carlson, M., Carling, D. (2005) Ca2{thorn}/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2 21-33.
98. Hurley, R. L., Anderson, K. A., Franzone, J. M., Kemp, B. E., Means, A. R., Witters, L. A. (2005) The Ca2{thorn}/ calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280 29060-29066.
99. Boudeau, J., Sapkota, G., Alessi, D. R. (2003) LKB1, a protein kinase regulating cell proliferation and polarity. FEBS Lett. 546 159-165.
100. Motoshima, H., Goldstein, B. J., Igata, M., Araki, E. (2006) AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 574 63-71.
101. Jaleel, M., McBride, A., Lizcano, J. M., Deak, M., Toth, R., Morrice, N. A., Alessi, D. R. (2005) Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett. 579 1417-1423.
102. Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., Cantley, L. C. (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6 91-99.
103. Inoki, K., Zhu, T., Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 577-590.
104. Boudeau, J., Baas, A. F., Deak, M., Morrice, N. A., Kieloch, A., Schutkowski, M., Prescott, A. R., Clevers, H. C., Alessi, D. R. (2003) MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 22 5102-5114.
105. Boudeau, J., Scott, J. W., Resta, N., Deak, M., Kieloch, A., Komander, D., Hardie, D. G., Prescott, A. R., van Aalten, D. M., Alessi, D. R. (2004) Analysis of the LKB1-STRAD-MO25 complex. J. Cell Sci. 117 6365-6375.
106. Sakamoto, K., McCarthy, A., Smith, D., Green, K. A., Grahame Hardie, D., Ashworth, A., Alessi, D. R. (2005) Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24 1810-1820.
107. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M., Cantley, L. C. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 1642-1646.
108. Hook, S. S., Means, A. R. (2001) Ca(2{thorn})/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 41 471-505.
109. Soderling, T. R. (1999) The Cacalmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 24 232-236.
110. Soderling, T. R., Chang, B., Brickey, D. (2001) Cellular signaling through multifunctional Ca2{thorn}/calmodulindependent protein kinase II. J. Biol. Chem. 276 3719-3722.
111. Soderling, T. R., Stull, J. T. (2001) Structure and regulation of calcium/ calmodulin-dependent protein kinases. Chem. Rev. 101 2341-2352.
112. Peters, M., Mizuno, K., Ris, L., Angelo, M., Godaux, E., Giese, K. P. (2003) Loss of Ca2{thorn}/calmodulin kinase kinase beta affects the formation of some, but not all, types of hippocampus-dependent long-term memory. J. Neurosci. 23 9752-9760.
113. Andersson, U., Filipsson, K., Abbott, C. R., Woods, A., Smith, K., Bloom, S. R., Carling, D., Small, C. J. (2004) AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279 12005-12008.
114. Anderson, K. A., Noeldner, P. K., Reece, K., Wadzinski, B. E., Means, A. R. (2004) Regulation and function of the calcium/ calmodulin-dependent protein kinase IV/protein serine/threonine phosphatase 2A signaling complex. J. Biol. Chem. 279 31708-31716.
115. Stahmann, N., Woods, A., Carling, D., Heller, R. (2006) Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2{thorn}/calmodulin-dependent protein kinase kinase beta. Mol. Cell. Biol. 26 5933-5945.
116. Tamas, P., Hawley, S. A., Clarke, R. G., Mustard, K. J., Green, K., Hardie, D. G., Cantrell, D. A. (2006) Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2{thorn} in T lymphocytes. J. Exp. Med. 203 1665-1670.
117. Momcilovic, M., Hong, S. P., Carlson, M. (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 281 25336-25343.
118. Xie, M., Zhang, D., Dyck, J. R., Li, Y., Zhang, H., Morishima, M., Mann, D. L., Taffet, G. E., Baldini, A., Khoury, D. S., Schneider, M. D. (2006) A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl. Acad. Sci. U.S.A. 103 17378-17383.
119. Horman, S., Vertommen, D., Heath, R., Neumann, D., Mouton, V., Woods, A., Schlattner, U., Wallimann, T., Carling, D., Hue, L., Rider, M. H. (2006) Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J. Biol. Chem. 281 5335-5340.
120. Kovacic, S., Soltys, C. L., Barr, A. J., Shiojima, I., Walsh, K., Dyck, J. R. (2003) Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem. 278 39422-39427.
121. Hurley, R. L., Barre, L. K., Wood, S. D., Anderson, K. A., Kemp, B. E., Means, A. R., Witters, L. A. (2006) Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281 36662-36672.
122. Collins, S. P., Reoma, J. L., Gamm, D. M., Uhler, M. D. (2000) LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem. J. 345 673-680.
123. Marley, A. E., Sullivan, J. E., Carling, D., Abbott, W. M., Smith, G. J., Taylor, I. W., Carey, F., Beri, R. K. (1996) Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha. Biochem. J. 320 801-806.
124. Moore, F., Weekes, J., Hardie, D. G. (1991) Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMPactivated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. . Eur. J. Biochem. 199 691-697.
125. Wang, M. Y., Unger, R. H. (2005) Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. Am. J. Physiol. 288, E216-221.
126. Hue, L., Beauloye, C., Bertrand, L., Horman, S., Krause, U., Marsin, A.-S., Meisse, D., Vertommen, D., Rider, M. H. (2003) New targets of AMP-activated protein kinase. Biochem. Soc. Trans. 31 213-215.
127. Dale, S., Wilson, W. A., Edelman, A. M., Hardie, D. G. (1995) Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett. 361 191-195.
128. Scott, J. W., Norman, D. G., Hawley, S. A., Kontogiannis, L., Hardie, D. G. (2002) Protein kinase substrate recognition studied using the recombinant catalytic domain of AMPactivated protein kinase and a model substrate. J. Mol. Biol. 317 309-323.
129. Krebs, E. G., Beavo, J. A. (1979) Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48 923-959.
130. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., Moller, D. E. (2001) Role of AMPactivated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 1167-1174.
131. Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S. C., Lemarchand, P., Ferre, P., Foufelle, F., Carling, D. (2000) Characterization of the role of AMPactivated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20 6704-6711.
132. Viollet, B., Andreelli, F., Jorgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., Gomas, E., Nicolas, G., Wojtaszewski, J. F., Kahn, A., Carling, D., Schuit, F. C., Birnbaum, M. J., Richter, E. A., Burcelin, R., Vaulont, S. (2003) The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111 91-98.
133. Jorgensen, S. B., Viollet, B., Andreelli, F., Frosig, C., Birk, J. B., Schjerling, P., Vaulont, S., Richter, E. A., Wojtaszewski, J. F. (2004) Knockout of the alpha2 but not alpha1 50-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contractioninduced glucose uptake in skeletal muscle. J. Biol. Chem. 279 1070-1079.
134. Cidad, P., Almeida, A., Bolanos, J. P. (2004) Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 50-AMP-activated protein kinase. Biochem. J. 384 629-636.
135. Horike, N., Takemori, H., Katoh, Y., Doi, J., Min, L., Asano, T., Sun, X. J., Yamamoto, H., Kasayama, S., Muraoka, M., Nonaka, Y., Okamoto, M. (2003) Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J. Biol. Chem. 278 18440-18447.
136. Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, J. R., 3rd, Takemori, H., Okamoto, M., Montminy, M. (2004) The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 119 61-74.
137. Koo, S. H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H., Montminy, M. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 1109-1111.
138. Baas, A. F., Smit, L., Clevers, H. (2004) LKB1 tumor suppressor protein: PARtaker in cell polarity. Trends Cell Biol. 14 312-319.
139. Lefebvre, D. L., Rosen, C. F. (2005) Regulation of SNARK activity in response to cellular stresses. Biochim. Biophys. Acta 1724 71-85.
140. Sakamoto, K., Goransson, O., Hardie, D. G., Alessi, D. R. (2004) Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am. J. Physiol. 287, E310-317.
141. Daval, M., Diot-Dupuy, F., Bazin, R., Hainault, I., Viollet, B., Vaulont, S., Hajduch, E., Ferre, P., Foufelle, F. (2005) Anti-lipolytic action of AMPactivated protein kinase in rodent adipocytes. J. Biol. Chem. 280 25250-25257.
142. Corton, J. M., Gillespie, J. G., Hawley, S. A., Hardie, D. G. (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur. J. Biochem. 229 558-565.
143. Sullivan, J. E., Brocklehurst, K. J., Marley, A. E., Carey, F., Carling, D., Beri, R. K. (1994) Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353 33-36.
144. Garton, A. J., Campbell, D. G., Carling, D., Hardie, D. G., Colbran, R. J., Yeaman, S. J. (1989) Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur. J. Biochem. 179 249-254.
145. Anthonsen, M. W., Ronnstrand, L., Wernstedt, C., Degerman, E., Holm, C. (1998) Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J. Biol. Chem. 273 215-221.
146. Watt, M. J., Holmes, A. G., Pinnamaneni, S. K., Garnham, A. P., Steinberg, G. R., Kemp, B. E., Febbraio, M. A. (2006) Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. 290, E500-508.
147. Rider, M. H., Bertrand, L., Vertommen, D., Michels, P. A., Rousseau, G. G., Hue, L. (2004) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J. 381 561-579.
148. Chen, Z. P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodriguez-Crespo, I., Witters, L. A., Power, D. A., Ortiz de Montellano, P. R., Kemp, B. E. (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 443 285-289.
149. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., Zeiher, A. M. (1999) Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 399 601-605.
150. Sano, H., Kane, S., Sano, E., Miinea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., Lienhard, G. E. (2003) Insulinstimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278 14599-14602.
151. Treebak, J. T., Glund, S., Deshmukh, A., Klein, D. K., Long, Y. C., Jensen, T. E., Jorgensen, S. B., Viollet, B., Andersson, L., Neumann, D., Wallimann, T., Richter, E. A., Chibalin, A. V., Zierath, J. R., Wojtaszewski, J. F. (2006) AMPKmediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55 2051-2058.
152. Kramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F., Goodyear, L. J. (2006) Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55 2067-2076.
153. Horman, S., Beauloye, C., Vertommen, D., Vanoverschelde, J. L., Hue, L., Rider, M. H. (2003) Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J. Biol. Chem 278 41970-41976.
154. Bolster, D. R., Crozier, S. J., Kimball, S. R., Jefferson, L. S. (2002) AMPactivated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277 23977-23980.
155. Horman, S., Browne, G. J., Krause, U., Patel, J. V., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C. G., Rider, M. H. (2002) Activation of AMPactivated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12 1419-1423.
156. Krause, U., Bertrand, L., Hue, L. (2002) Control of p70 ribosomal protein S6 kinase and acetylCoA carboxylase activity by AMP-activated protein kinase and protein phosphatases in isolated rat hepatocytes. Eur. J. Biochem. 269 3751-3759.
157. Inoki, K., Li, Y., Zhu, T., Wu, J., Guan, K. L. (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4 648-657.
158. Nave, B. T., Ouwens, M., Withers, D. J., Alessi, D. R., Shepherd, P. R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and aminoacid deficiency on protein translation. Biochem. J. 344 427-431.
159. Cheng, S. W., Fryer, L. G., Carling, D., Shepherd, P. R. (2004) Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 279 15719-15722.
160. Fryer, L. G., Parbu-Patel, A., Carling, D. (2002) The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277 25226-25232.
161. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., Thompson, C. B. (2005) AMPactivated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18 283-293.
162. Kimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K., Kemp, B. E., Witters, L. A., Mimura, O., Yonezawa, K. (2003) A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8 65-79.
163. Motoshima, H., Goldstein, B. J., Igata, M., Araki, E. (2006) AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 574 63-71.
164. Munday, M. R., Campbell, D. G., Carling, D., Hardie, D. G. (1988) Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur. J. Biochem. 175 331-338.
165. Winder, W. W., Wilson, H. A., Hardie, D. G., Rasmussen, B. B., Hutber, C. A., Call, G. B., Clayton, R. D., Conley, L. M., Yoon, S., Zhou, B. (1997) Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J. Appl. Physiol. 82 219-225.
166. Ching, Y. P., Davies, S. P., Hardie, D. G. (1996) Analysis of the specificity of the AMP-activated protein kinase by sitedirected mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique-site-elimination method. Eur. J. Biochem. 237 800-808.
167. Carling, D., Hardie, D. G. (1989) The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim. Biophys. Acta 1012 81-86.
168. Marsin, A.-S., Bouzin, C., Bertrand, L., Hue, L. (2002) The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem. 277 30778-30783.
169. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T., Uyeda, K. (2002) Mechanism for fatty acid ''sparing'' effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMPactivated protein kinase. J. Biol. Chem. 277 3829-3835.
170. Hong, Y. H., Varanasi, U. S., Yang, W., Leff, T. (2003) AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem. 278 27495-27501.
171. Yang, W., Hong, Y. H., Shen, X. Q., Frankowski, C., Camp, H. S., Leff, T. (2001) Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J. Biol. Chem. 276 38341-38344.
172. Browne, G. J., Finn, S. G., Proud, C. G. (2004) Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. 279 12220-12231.
173. Jakobsen, S. N., Hardie, D. G., Morrice, N., Tornqvist, H. E. (2001) 50-AMPactivated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276 46912-46916.
174. Sprenkle, A. B., Davies, S. P., Carling, D., Hardie, D. G., Sturgill, T. W. (1997) Identification of Raf-1 Ser621 kinase activity from NIH 3T3 cells as AMPactivated protein kinase. FEBS Lett. 403 254-258.